Mechanism of combined action of 18 α-diammonii glycyrrhizinatis and glibenclamide on glucose metabolism in experimental diabetic rats

Chinese Journal of Pharmacology and Toxicology

Volumn 19, Issue 4, 2005, Pages 274-279

  Chen, Jie ^a   Peng, Ren Xiu ^a   Yang, Jing ^a   Lu, Jing Feng ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

18 diammonii glycyrrhizinatis; Blood glucose; Cytochrome P 450 CYP3A; Diabetes mellitus, experimental; Drug synergism; Glibenclamide; Insulin; Liver function tests

Indexed keywords

18 ALPHA DIAMMONII GLYCYRRHIZINATIS; ANTIDIABETIC AGENT; CYTOCHROME P450 3A; GLIBENCLAMIDE; INSULIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DIABETES MELLITUS; DRUG MECHANISM; GLUCOSE METABOLISM; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; NONHUMAN; RAT;

ANIMALIA;

EID: 25444474186     PISSN: 10003002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Naritomi Y, Terashita S, Kagayama A. Identification and relative contributions of human cytochrome P450 isoforms involved in the metabolism of glibenclamide and lansoprazole: evaluation of an approach based on the in vitro substrate disappearance rate[J]. Xenobiotica, 2004, 34(5): 415-427.
2. van Giersbergen PL, Treiber A, Clozel M, Bodin F, Dingemanse J. In vivo and in vitro studies exploring the pharmacokinetic interaction between bosentan, a dual endothelin receptor antagonist, and glyburide[J]. Clin Pharmacol Ther, 2002, 71(4):253-262.
3. Jiao JJ, Weng FH, Wu WF, Zhang YH. Effects of rifampicin on the pharmacokinetics and hypoglycemic action of glibenclamide in rabbits[J]. Chin Pharm J (Chinese characters), 1995, 30(3):147-150.
4. Roberge RJ, Kaplan R, Frank R, Fore C. Glyburide-ciprofloxacin interaction with resistant hypoglycemia[J]. Ann Emerg Med, 2000, 36(2):160-163.
5. Yang J, Peng RX, Kong R, Yu JP. Effects of 18 α-glycyrrhizic acid on rat liver cytochrome P450 isoenzymes and phase II transferase[J]. Acta Pharm Sin (Chinese characters), 2001, 36(5):321-324.
6. Lin ZB. Experiments of antihyperglycemic drugs[A]. In: Xu SY, Bian RL, Chen X, ed. Methodology of Pharmacological Experiments (Chinese characters)[M]. 3rd ed. Beijing: People's Medical Publishing House, 2002. 1517-1519.
7. Ye F. Method for the determination of glycogen synthesis [A]. In: Zhang JT, ed. Modern Methods of Pharmacological Experiment (Chinese characters)[M]. Beijing: The Union Press of Beijing Medical University and Chinese Academy of Medical Sciences, Peking Union Medical College, 1998. 1006-1007.
8. Sun SJ, Shen ZF, Chen YT, Tang L, Ding SY, Xie MZ. Effects of conjugated linoleic acid on obese MSG mice with insulin resistance[J]. Acta Pharm Sin (Chinese characters), 2003, 38(12):904-907.
9. Peng RX, Wang YS, Lei SB. Characterization of monooxygenase system in Chinese fetal adrenal gland[J]. Asian Pac J Pharmacol, 1994, 9(1):195-200.
10. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent[J]. J Biol Chem, 1951, 193(1):265-275.
11. Jin YY. Insulin and oral antidiabetic drug[A]. In: Jin YY, eds. Pharmacology(Chinese characters) [M]. 5th ed. Beijing: People's Medical Publishing House, 2002. 303-304.
12. Zheng QZ, Lou YJ. Pathologic characteristics of immunologic injury in primary cultured rat hepatocytes and protective effect of glycyrrhizin in vitro[J]. Acta Pharmacol Sin (Chinese characters), 2003, 24(8):771-777.